Navigation Links
ESF's EMRC strengthens training course on clinical trials management
Date:2/14/2008

Around 170 doctors, nurses and medical researchers from Europe and North America were given important insights into how to run successful clinical trials across national boundaries at a two-day training course in Croydon, UK.

The course, sponsored by the European Science Foundation as part of its Pan-European Clinical Trials (ECT) programme, heard expert speakers on all aspects of clinical trials with a specific focus on the Euramos trial into the rare bone cancer osteosarcoma.

Dr. Carole Moquin-Pattey, head of the European Medical Research Councils (EMRC) unit from the ESF, said, It is crucial to have so many dedicated people sharing their expertise and experience. International collaboration on investigator-driven clinical trials is going to become increasingly important and workshops such as these are vital to help us improve and simplify the management of the many complex issues involved.

ESF is co-ordinating two clinical trials through its EUROCORES scheme. These trials are into two rare bone conditions, osteosarcoma (Euramos) and fibrous dysplasia (Profidys). International and European collaborations are vital for such rare conditions because no single country has sufficient patients to launch a study that would yield meaningful results.

Patients are currently being recruited to the studies and the meeting heard that recruitment is on target. The two ECT projects are proving crucial in laying the foundations for subsequent international trials: ESFs membership organisation for medical research councils across Europe, European Medical Research Councils (EMRC) recently announced a strategic review of cross-border trials, called a Forward Look, to pave the way for future investigator-driven clinical trials.

Topics discussed at the meeting in Croydon, on January 24 and 25, included tips on how best to present information to potential recruits to trials, regulations surrounding the reporting of adverse events affecting patients, how to ensure that the targeted number of patients are randomised in the trial in a timely manner, and key issues relating to the role of clinical pharmacists.


'/>"/>

Contact: Thomas Lau
tlau@esf.org
33-388-762-158
European Science Foundation
Source:Eurekalert

Related medicine news :

1. HEALTHeCAREERS Network Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
2. Heraeus Strengthens Medical Components Business
3. MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling $4 Million
4. Dowden Custom Media Strengthens e-Media
5. Scientx USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
6. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
7. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
8. Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
9. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
10. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
11. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, eyewear, ... the rarified air of pop and film stardom.(1) Not to be left out is ... smile. Grins now run the gamut from being encrusted with jewels and precious metals ...
(Date:4/24/2017)... ... ... The John P. McGovern Museum of Health and Medical Science is now partnered with ... share results with their physicians. Members and guests can sign up for its free ... Dr. David Eagleman, formerly at Baylor College of Medicine and now at Stanford University, ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, a leading provider of ... that Kyle Allain has joined the company as Vice President and General Manager ... provider, payor and managed care solutions. , A seasoned executive with more ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively new ... is not known to have significant interactions with antiretroviral therapy (ART). Among ... levels and dampen inflammation in the bloodstream. , While lowering cholesterol and dampening ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... shows that over the last decade, student well-being has seriously declined. "When disenfranchised ... of formal education, join the Islamic State to turn the historic multi-ethnic and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... -- Viverae ® , a leader in workplace wellness ... ® Watson Campaign Automation, implementing behavioral messaging within ... personalized experience. Through digital engagement, the platform prompts members ... time. The enhanced experience drives engagement by focusing on ... are in their journey to health. ...
(Date:4/18/2017)... April 18, 2017  Socionext Inc. and SOINN ... in 2016, in which Socionext extracts and delivers ... companies achieved initial results in reading ultrasound images ... Brain SOINN. The results will be introduced at ... 19-21, at booths 4505 & 4507. ...
Breaking Medicine Technology: